We examined the effects of sesamol on the lipopolysaccharide (LPS)-induced inflammatory response. Sesamol inhibited serum tumor necrosis factor (TNF)-α, interleukin (IL)-1β and nitrite production in LPS-treated mice, and inhibited LPS-induced inducible nitric oxide synthase expression in mouse leukocytes. Sesamol also down-regulated TNF-α, IL-1β, and nitrite production as well as inducible nitric oxide synthase expression in LPS-treated RAW 264.7 cells. Further, sesamol inhibited LPS-induced nuclear factor (NF)-κB translocation and inhibitor (I)κB-α phosphorylation in RAW 264.7 cells. By inhibiting TNF-α, IL-1β, and nitrite levels, and interfering with the NFκB pathway, sesamol down-regulated the LPS-initiated inflammatory response.
Bone RCToward a theory regarding the pathogenesis of systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med1996; 24: 163-172.
Hornef MW, Wick MJ, Rhen M., Normark S.Bacterial strategies for overcoming host innate and adaptive immune responses . Nat Immunol2002; 3: 1033-1040.
4.
Guha M., Mackman N.LPS induction of gene expression in human monocytes. Cell Signal2001; 13: 85-94.
5.
Chen H., Cowan MJ, Hasday JD, Vogel SN, Medvedev AETobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappa B in alveolar macrophages stimulated with TLR2 and TLR4 agonists. J Immunol2007 ; 179: 6097-6106.
6.
Treon SP, Anand B., Ulevitch RJ, Broitman SACD14 mediated endogenous TNF-alpha release in HL60 AML cells: a potential model for CD14 mediated endogenous cytokine release in the treatment of AML . Leukoc Res1994; 18: 17-21.
7.
Ghosh S., May MJ, Kopp EBNF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol1998; 16: 225-260.
8.
Jung YJ, Isaacs JS, Lee S., Trepel J., Neckers L.IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/ COX-2 pathway indentifies HIF-1 as a critical link between inflammation and oncogenesis . FASEB J2003; 17: 2115-2117.
9.
Baldwin ASThe NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol1996; 14: 649-683.
10.
Karin M., Ben-Neriah Y.Phosphorylation meets ubiquitination: the control of NF-kappa B activity. Annu Rev Immunol2000; 18: 621-663.
11.
Abraham E.NF-kappaB activation. Crit Care Med2000; 28: N100-N104.
12.
Hsu DZ, Chen KT, Li YH, Chuang YC, Liu MYSesamol delays mortality and attenuates hepatic injury after cecal ligation and puncture in rats: role of oxidative stress. Shock2006; 25: 528-532.
13.
Hsu DZ, Li YH, Chu PY, Chuang YC, Liu MYAttenuation of endotoxin-induced oxidative stress and multiple organ injury by 3,4-methylenedioxyphenol in rats. Shock2006; 25: 300-305.
14.
Hsu DZ, Liu MYBicuculline methiodide attenuates hepatic injury and decreases mortality in septic rats: role of cytokines. Shock2008 ; 22: 347-350.
15.
Hsu DZ, Chiang PJ, Chien SP, Huang BU, Liu MYParenteral sesamol oil attenuates oxidative stress after endotoxin in rats . Toxicology2004; 196: 147-153.
16.
Green LC, Ruiz de Luzuriaga K., Wagner DA et al. Nitrate biosynthesis in man. Proc Natl Acad Sci USA1981; 78: 7764-7768.
17.
Waage A., Halstensen A., Espevik T.Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet1987; 1: 355-357.
18.
Henderson B. , Pettipher ERArthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol1989; 75: 306-310.
19.
Stashenko P. , Dewhirst FE, Peros WJ, Kent RL, Ago JMSynergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol1987; 138: 1464-1468.
20.
Waage A., Espevik T.Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice. J Exp Med1988; 167: 1987-1992.
21.
Flores EA, Bistrian BR, Pomposelli JJ et al. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1. J Clin Invest1989; 83: 1614-1622.
22.
Van der Meer MJ, Sweep CG, Pesman GJ, Borm GF, Hermus ARSynergism between IL-1beta and TNF-alpha on the activity of the pituitary-adrenal axis and on food intake of rats. Am J Physiol1995; 268: 551-557.
23.
Clark MA, Plank LD, Connolly AB et al. Effect of a chimeric antibody to tumor necrosis factor-α on cytokine and physiologic responses in patients with severe sepsis - a randomized, clinical trial. Crit Care Med1998; 26: 1650-1659.
24.
Fisher CJ, Agosti JM, Opal SM et al. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. N Engl J Med1996; 334: 1697-1702.
25.
Opal SM, Fisher CJ, Dhainaut JF et al. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. Crit Care Med1997; 25: 1115-1124.
26.
Shembade N. , Harhaj NS, Liebl DJ, Harhaj EWEssential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPSmediated NF-kappaB and JNK signaling. EMBO J2007; 26: 3910-3922.
27.
Kim do Y., Jun JH, Lee HL et al. N-Acetylcysteine prevents LPS-induced pro-inflammatory cytokines and MMP2 production in gingival fibroblasts. Arch Pharm Res2007; 30: 1283-1292.
28.
Williams JG , Bernstein S., Prager M.Effect of melatonin on activated macrophage TNF, IL-6, and reactive oxygen intermediates. Shock1998; 9: 406-611.
29.
Chavali SR, Utsunomiya T., Forse RAIncreased survival after cecal ligation and puncture in mice consuming diets enriched with sesame seed oil. Crit Care Med2001; 29: 140-143.
30.
Xing L., Remick DGMechanisms of dimethyl sulfoxide augmentation of IL-1β production. J Immunol2005; 174: 6195-6202.
